Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Funding Amount
Not stated
Deadline
May 25, 2029
951 days left
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Nonprofits without 501(c)(3) status
- Private colleges & universities
- Nonprofits (501(c)(3))
- Public colleges & universities
Geography
- Located in an IDeA-eligible state, commonwealth, or jurisdiction, which are
Overview
Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE E/S)
The Institutional Development Award (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) Notice of Funding Opportunity (NOFO) will support the expansion and sustainability of biomedical research centers in IDeA-eligible institutions. These centers will focus on building research capacity in broad scientific areas of strategic importance for the institutions. The goal of COBRE-E is to expand research capacity by growing the institutional faculty base and supporting research projects and core facilities in the new area. The objective of COBRE-S is to sustain the infrastructure by continuing the growth of the faculty base and consolidating research cores. Applicants are expected to propose a sustainability plan during the COBRE-E Phase for implementation in the COBRE-S Phase.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: PAR-26-031
- Instrument: grant
Eligibility
Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are: Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.
Focus Areas & Funding Uses
Fields of Work
- Science research
- Capacity building
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 19, 2026
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
Amount
$2,900,000 total
Deadline
October 19, 2026
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health
Amount
$50K – $600K
Deadline
October 19, 2026
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
National Institutes of Health
Amount
$10,200,000 total
Deadline
October 19, 2026
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
National Institutes of Health
Amount
$3,600,000 total
Deadline
October 20, 2026
Ready to apply for Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed). Now let's win it.